Table 1

At-risk participant characteristics

Participant noGenderAge at interview (years)CCP dental study* statusSmoking (ever/never)MSK symptoms (Y/N)Oral health symptoms† (Y/N)First degree relative with RA (Y/N)
1Female60Had assessment and accepted treatmentNeverYYN
2Male41Had assessment and accepted treatmentNeverYYN
3Female55Had assessment and accepted treatmentNeverYYN
4Female56Had assessment and accepted treatmentNeverYNN
5Female50Had assessment, declined treatmentEverYYY (grandmother)
6Male42Had assessment and would accept treatmentNeverYYY
7Male53Had assessment and accepted treatmentNeverYNN
8Male70Had assessment and accepted treatmentEverNYN
9Female35Had assessment and would accept treatmentEverYNN
10Female62Had assessment and would accept treatmentNeverYYN
11Female55Not approachedNeverYYN
12Male61Not approachedNeverYYUnconfirmed (grandmother)
13Male54Declined assessmentEverYYY (grandfather)
14Male38Had assessment, declined treatmentEverYYY (mother)
15Female40Had assessment and would accept treatmentNeverYYN
16Male60Not approachedEverYYN
17Female56Had assessment, accepted treatmentEverYYN
18Male56Not approachedNeverYYY (father)
19Female52Declined assessment and treatmentEverYNN
  • *CCP dental study in which CCP+ at-risk participants are offered periodontal treatment.

  • †MSK/oral health symptoms within 9 months preceding the interview.

  • MSK, musculoskeletal; RA, rheumatoid arthritis.